Abstract:Abstract Background Recent studies have suggested that the gut microbiota is altered in children with juvenile idiopathic arthritis (JIA). However, age, sex, and body mass index (BMI) were not matched in the previous studies, and the results are inconsistent. We conducted an age-, sex-, and BMI-matched cross-sectional study to characterize the gut microbiota in children with JIA, and evaluate its potential in clinical prediction. Methods A total of 40 patients with JIA and 42 healthy controls, ranging from 1 to 16 years, were enrolled in this study. Fecal samples were collected for 16S rDNA sequencing. The data were analyzed using QIIME software and R packages. Specifically, the random forest model was used to identify biomarkers, and the receiver operating characteristic curve and the decision curve analysis were used to evaluate model performance. Results A total of 39 fecal samples from patients with JIA, and 42 fecal samples from healthy controls were sequenced successfully. The Chao 1 and Shannon–Wiener index in the JIA group were significantly lower than those in the control group, and the Bray-Curtis dissimilarity also differed significantly between the two groups. The relative abundance of 4 genera, Anaerostipes, Dialister, Lachnospira, and Roseburia, decreased significantly in the JIA group compared to those in the control group. The 4 genera included microbes that produce short-chain fatty acids (SCFAs) and were negatively correlated with some rheumatic indices. Moreover, 12 genera were identified as potential biomarkers by using the nested cross-validation function of the random forest. A random forest model constructed using these genera was able to differentiate the patients with JIA from the healthy controls, and the area under the receiver operating characteristic curve was 0.7975. The decision curve analysis indicated that the model had usefulness in clinical practice. Conclusions The gut microbiota in patients with JIA is altered and characterized by a decreased abundance of 4 SCFA-producing genera. The decreases in the 4 genera correlated with more serious clinical indices. Twelve genera could be used as biomarkers and predictors in clinical practice. Trial registration The study is registered online at the Chinese Clinical Trial Registry on 11 May 2018 (registration number: ChiCTR1800016110).

Gut microbiome-immune interactions and their role in rheumatoid arthritis development

The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study

Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

The rheumatoid arthritis gut microbial biobank reveals core microbial species that associate and effect on host inflammation and autoimmune responses

Gut Microbiota in Children with Juvenile Idiopathic Arthritis: Characteristics, Biomarker Identification, and Usefulness in Clinical Prediction.

Multidimensional profile of gut microbiota in a large cohort of stratified rheumatoid arthritis

Microbiome–miRNA Interactions in the Progress from Undifferentiated Arthritis to Rheumatoid Arthritis: Evidence, Hypotheses, and Opportunities

Exploring the significance of microbiota metabolites in rheumatoid arthritis: uncovering their contribution from disease development to biomarker potential

The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis

Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis

Hidden link in gut–joint axis: gut microbes promote rheumatoid arthritis at early stage by enhancing ascorbate degradation

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment

Alterations of the intestinal microbiome and metabolome in women with rheumatoid arthritis

Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China

Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis

The role of microbiota on rheumatoid arthritis onset

The Gut Microbiota and Its Relevance to Peripheral Lymphocyte Subpopulations and Cytokines in Patients with Rheumatoid Arthritis

Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance

Arthritis susceptibility and the gut microbiome

Alterations of gut fungal microbiota in patients with rheumatoid arthritis

Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis